Systemic | Oligo-p | Oligo-e | RF- poly | RF+ poly | Psoriatic | Enthesitis | |
---|---|---|---|---|---|---|---|
N | 18 | 63 | 6 | 40 | 12 | 3 | 18 |
Age (yrs) | 10.7 (5.8, 19.9) | 9.9 (2.6, 18.6) | 15.3 (10.8, 21.1) | 11.2 (3.5,1 9.6) | 13.5 (8.9,20.1) | 12.9 (8.6,17.6) | 17.0 (9.7, 21.2) |
Gender (F/M) | 8/10 | 52/11 | 5/1 | 34/6 | 12/0 | 2/1 | 9/9 |
Onset age (yrs) | 5.5 (0.9, 13.0) | 3.7 (0.8, 15.8) | 8.2 (1.6, 14.8) | 4.5 (1,15.6) | 11.2 (6.7,15.6) | 7.3 (6.3,13.0) | 10.3 (3.0, 15.6) |
Diagnostic age (yrs) | 6.1 (1.0, 13.3) | 4.3 (1, 16.6) | 9.2 (1.9, 15.3) | 5.4 (1.3, 17.3) | 11.8 (6.9,16.1) | 7.4 (7.3,13.4) | 13.2 (9.7, 18.4) |
Duration from diagnosis (yrs) | 0.1 (0,1.1) | 0.3 (0, 10.0) | 0.3 (0, 2.0) | 0.4 (0.0, 5.4) | 0.4 (0,1.0) | 0.3 (0.2,1.0) | 2.1 (0, 5.3) |
ANA+ n (%) | 4 (22%) | 36 (57%) | 4 (67%) | 15 (37.5%) | 7 (58%) | 1 (33%) | 9 (50%) |
RF+ n (%) | 0 (0%) | 1 (1.5%) | 1 (16.7%) | 0 (0%) | 12 (100%) | 1 (33%) | 1 ((5.6%) |
B27+ n (%) | n/a | 1 (1.5%) | 1 (16.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (33%) |
Race/Ethn. | |||||||
White/non-Hispanic | 14 | 48 | 6 | 32 | 8 | 2 | 14 |
Hispanic | 1 | 7 | 7 | 3 | 2 | ||
African American | 2 | 1 | 1 | 1 | |||
Asian | 1 | 3 | 1 | ||||
Other | 4 | 1 | 1 |